Rotterdam, the Netherlands, April 16, 2025 (GLOBE NEWSWIRE) — The Global Center on Adaptation (GCA) today hosted an inaugural Ambassadors’ Forum galvanizing global support for accelerating adaptation at speed and
Rotterdam, the Netherlands, April 16, 2025 (GLOBE NEWSWIRE) — The Global Center on Adaptation (GCA) today hosted an inaugural Ambassadors’ Forum galvanizing global support for accelerating adaptation at speed and
Sabin Begins Marburg Vaccine Clinical Trial in U.S. Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S. WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) —
Sabin Begins Marburg Vaccine Clinical Trial in U.S. WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S.
KIGALI, Rwanda, April 16, 2025 (GLOBE NEWSWIRE) — The Clinton Health Access Initiative (CHAI) and the OneSight EssilorLuxottica Foundation have announced a multi-year partnership to advance access to eyeglasses and
KIGALI, Rwanda, April 16, 2025 (GLOBE NEWSWIRE) — The Clinton Health Access Initiative (CHAI) and the OneSight EssilorLuxottica Foundation have announced a multi-year partnership to advance access to eyeglasses and
